FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:1789-1790 October 21, 2004 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

In the debate between those who support federal funding for embryonic stem-cell research and those who do not, a critical point has been overlooked. Research using this technology is strongly supported in a number of countries, including Australia, Israel, the Czech Republic, Singapore, Korea, and the United Kingdom. Others in the world appreciate the potential of this technology. If we continue to prevent federal funds from being used to support this research in the United States, the ability of our biomedical scientists to compete with other research teams throughout the world will be undermined. No matter how hard we try, . . . [Full Text of this Article]

Related Letters:

Federal Funding for Stem-Cell Research
Matz R.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:307, Jan 20, 2005. Correspondence

This article has been cited by other articles:

• Matz, R. (2005). Federal Funding for Stem-Cell Research. NEJM 352: 307-307 [Full Text]